- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03401424
Comparison of Two Kinds of Biliary Intestinal Reconstruction in Cholangiectasia
January 15, 2018 updated by: Shuguo Zheng, MD, Southwest Hospital, China
The RCT Study of Two Surgical Biliary-enteric Reconstruction Minimally Invasive Treatment of Bile Duct Dilatation
To observe and compare the short-term and long-term effects of different biliary and intestinal reconstruction methods for the treatment of congenital cystic dilatation of bile duct .
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The purpose of the study: length of operation time, postoperative intestinal function recovery time as the main index, application prospective clinical study to observe the differences were followed by two different laparoscopic biliary intestinal kiss the short-term and long-term effect of the treatment of congenital cystic dilatation of the bile duct, provide a higher level of evidence based medicine dilatation of patients for congenital bile duct cysts.
The choice of second is based on the study, effective, objective evaluation of different laparoscopic biliary enteric reconstruction for the treatment of congenital cystic dilatation of the bile duct is feasible, clear surgical indications, contraindications and summarized the technical points, establish guidelines for clinical diagnosis and treatment of congenital cystic dilation of the bile duct disease.
Study Type
Interventional
Enrollment (Anticipated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Chongqing
-
Chongqing, Chongqing, China, 400038
- Recruiting
- Southwest Hospital
-
Contact:
- Shuguo Zheng, Professor
- Phone Number: 0086-13508308676
- Email: shuguozh@yahoo.com.cn
-
Principal Investigator:
- Shuguo Zheng
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 70 years (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- gender, age 5-70 years old (the disease can occur at any age, but in 80% cases of childhood onset, such as children's height and weight of endoscopic treatment for the standard, by parents as guardians into the group);
- preoperative congenital cystic dilatation of the bile duct (I, II, IV) clear diagnosis; preoperative assessment of liver function
- : Child-Pugh = B;
- bile duct without canceration;
- recurrent cholangitis, biliary calculi in the biliary tract infection was controlled in acute pancreatitis; control of inflammation;
- the treatment of choledochal cyst, without any surgical treatment;
- the general condition of the patient, heart and lung function can tolerate surgery, no absolute contraindication abdominal laparoscopic operation;
- voluntarily participated in the study, informed consent.
Exclusion Criteria:
- congenital cystic dilatation of the bile duct of III type, V type (III type feasible endoscope end of bile duct duodenal sphincterotomy, V type partial resection of the liver);
- patients who cannot tolerate pneumoperitoneum or serious abdominal adhesions, unable to carry out laparoscopic surgery;
- bad general condition or heart pulmonary dysfunction cannot tolerate surgery;
- severe cholestatic cirrhosis, severe portal hypertension;
- high risk patients with general anesthesia.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: improved Warren-type style
Minimally invasive treatment improved Warren-type cholangiocarcinoma reconstruction is easy
|
Select 60 cases of biliary dilatation in patients undergoing laparoscopic cyst excision plus modified Warren cholangiobiliary reconstruction.
|
|
ACTIVE_COMPARATOR: Roux-en-Y style
Early open cholecystectomy reconstruction surgery using Roux-en-Y style
|
Select 60 cases of biliary dilatation in patients undergoing laparoscopic cyst excision Roux-en-Y cholangiobiliary reconstruction.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
operation time
Time Frame: 2 years
|
Two surgical methods operation time
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 1, 2017
Primary Completion (ANTICIPATED)
June 1, 2019
Study Completion (ANTICIPATED)
June 1, 2020
Study Registration Dates
First Submitted
December 28, 2017
First Submitted That Met QC Criteria
January 15, 2018
First Posted (ACTUAL)
January 17, 2018
Study Record Updates
Last Update Posted (ACTUAL)
January 17, 2018
Last Update Submitted That Met QC Criteria
January 15, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SWHZSG008
- zhengshuguo (Registry Identifier: zhengshuguo)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postcholecystectomy Syndrome
-
DongGuk UniversityPharmbio Korea Co., Ltd.CompletedPostcholecystectomy SyndromeKorea, Republic of
-
Zagazig UniversityCompleted
-
Assiut UniversityUnknown
-
Assiut UniversityNot yet recruiting
-
South Valley UniversityCompletedCommon Bile Duct Injury
-
Patel Hospital, PakistanEnrolling by invitation
-
Xinhua Hospital, Shanghai Jiao Tong University...UnknownSphincter of Oddi DysfunctionChina
-
Valenta Pharm JSCRecruitingIrritable Bowel Syndrome | GERD | Biliary Dyskinesia | Postcholecystectomy Syndrome | Gallstone DiseaseRussia
-
AbbottCompletedPost-cholecystectomy Gastrointestinal SpasmsRussian Federation
-
University Hospital of CreteRecruitingDietary Habits | Cholelithiases | Postcholecystectomy Syndrome | Gallstone Disease | Gallstone; Colic | Gallstone; Cholecystitis, AcuteGreece
Clinical Trials on improved Warren-type style
-
National Taiwan University HospitalActive, not recruitingDevice DislocationTaiwan
-
Eulji University HospitalCompletedType 2 Diabetes | Insulin Sensitivity
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingProstate Carcinoma | Recurrent Prostate CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Metastatic Breast CarcinomaUnited States